Abstract
In a prospective, open, randomized controlled trial, 173 patients requiring surgery for potentially “contaminated” lower gastrointestinal surgery were allocated to receive either two doses of ceftizoxime (2 gm) with one dose of metronidazole (1.5 gm) or gentamicin 3 mg/kg/day for five days with one dose of metronidazole (1.5 gm). Eighty-nine patients received ceftizoxime and 84 patients received gentamicin. The groups were comparable with respect to diagnosis, procedure, type of anastomosis, and wound closure. The incidence of withdrawal due to failure to respond to the study drug (11.5 percent) was equivalent in the two groups. There was no difference in the overall incidence of postsurgical infection between the ceftizoxime and metronidazole group (22.2 percent) and the gentamicin and metronidazole group (25.7 percent). The incidence of wound infection (ceftizoxime and metronidazole, 6.9 percent; gentamicin and metronidazole, 10 percent) and deep sepsis (ceftizoxime and metronidazole, 15.3 percent; gentamicin and metronidazole, 15.7 percent) was similar.
Similar content being viewed by others
References
Hares MM, Bentley S, Allan RN, Burdon DW, Keighley MR. Clinical trials of the efficacy and duration of antibacterial cover for elective resection in inflammatory bowel disease. Br J Surg 1982;69:215–7.
Ambrose NS, Alexander-Williams J, Keighley MR. Audit of sepsis in operations for inflammatory bowel disease. Dis Colon Rectum 1984;27:602–4.
Tudor RG, Haynes I, Youngs DJ, Burdon DW, Keighley MR. Comparison of short-term antibiotic cover with a third generation cephalosporin against conventional five-day therapy using metronidazole with an aminoglycoside in emergency and complicated colorectal surgery. Dis Colon Rectum 1988;31:28–32.
Higgens C, Allan RN, Keighley MR, Arabi Y, Alexander-Williams J. Sepsis following operation for inflammatory intestinal disease. Dis Colon Rectum 1980;23:102–5.
Burton RC. Postoperative wound infection in colonic and rectal surgery. Br J Surg 1973;60:363–5.
Keighley MR, Arabi Y, Alexander-Williams J,et al. Comparison between systemic and oral antimicrobial prophylaxis in colorectal surgery. Lancet 1979;1:894–7.
Willis AT, Ferguson IR, Jones PH,et al. Metronidazole in prevention and treatment of bacteroides in elective colonic surgery. Br Med J 1977;1:607–10.
Downing R, McLeish AR, Burdon DW, Alexander-Williams J, Keighley MR. Duration of systemic prophylactic antibiotic cover against anaerobic sepsis in intestinal surgery. Dis Colon Rectum 1977;20:401–4.
Eykyn SJ, Jackson BT, Lockhard-Mummery HC,et al. Prophylactic preoperative intravenous metronidazole in elective colorectal surgery. Lancet 1979;2:761–3.
Morris DL, Fabricius PJ, Ambrose NS, Scammell B, Burdon DW, Keighley MR. A high incidence of bleeding is observed in a trial to determine whether addition of metronidazole is needed with latamoxef for prophylaxis in colorectal surgery. J Hosp Infect 1984;5:398–405.
Hares MM, Greca F, Youngs D, Bentley D, Burdon DW, Keighley MR. Failure of antimicrobial prophylaxis with cefoxitus or metronidazole and gentamicin in colorectal surgery: is mannitol to blame? J Hosp Infect 1981;2:127–33.
Keighley MR. Antibiotic associated pseudomembraneous colitis: pathogenesis and management. Drug 1980;20:49–56.
Ambrose NS, Burdon DW, Keighley MR. A prospective randomized trial to compare mezlocillin and metronidazole with cefuroxime and metronidazole in elective colorectal operations. J Hosp Infect 1983;4:375–82.
Ambrose NS, Johnson M, Burdon DW, Keighley MR. The influence of single dose intravenous antibiotics on faecal flora and emergence ofClostridium difficile. J Antimicrob Chemother 1985;15:319–26.
Author information
Authors and Affiliations
About this article
Cite this article
Winslet, M.C., Youngs, D., Burdon, D.W. et al. Short-term chemoprophylaxis with ceftizoximevs. Five-day aminoglycoside with metronidazole in ‘contaminated’ lower gastrointestinal surgery. Dis Colon Rectum 33, 878–882 (1990). https://doi.org/10.1007/BF02051926
Issue Date:
DOI: https://doi.org/10.1007/BF02051926